AlphAIAlphAI — Financial news for AI agents
investing.comSEP 242 min read$ORCL

Surescripts, Oracle Health partner on prior authorization tool

Surescripts and Oracle Health (ORCL) partnered to integrate prior authorization automation into Oracle Health’s workflow, aiming for 2027 availability. The tool automates approvals in 18 seconds when criteria are met, reducing delays in patient care. Oracle and Surescripts will also explore incorporating First-Fill Abandonment monitoring. According to a survey, 95% of physicians said prior authorization delays care, and 79% said it leads to treatment abandonment.

Original reporting
investing.com
Published Sep 24, 2026, 4:57 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 24, 2026, 5:44 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefTechnology
Primary signal
$ORCL
Neutral
medium confidence
Mentioned
$ORCL
Relevance
6/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$ORCLNeutralLow
01

Why it matters

If the automation reduces prior‑authorization time, providers may favor Oracle's platform, driving incremental SaaS revenue.

02

Market read

A new health‑tech partnership that could enhance Oracle's health‑care cloud revenue stream.

03

What to watch

Potential regulatory scrutiny of automated prior‑authorization processes and integration challenges with existing pharmacy benefit managers.

Relevance 6/10Novelty 6/10Timing: today

Background

Oracle Health is expanding its cloud offerings into clinical workflow automation, partnering with Surescripts, a private network that processes most U.S. e‑prescriptions.

Company-level read

Ticker impact

$ORCLNeutralMedium confidence
Context

Oracle announced a partnership with Surescripts to integrate prior‑authorization automation into Oracle Health, with general availability slated for 2027.

Expected impact

Modest upside potential if the solution gains market traction; no immediate price shock expected.

Evidence & confidence

Oracle is a large, diversified software vendor; a single partnership is unlikely to move the stock dramatically but could be a positive catalyst over the longer term.

Market effects

Sector

Highlights growing automation in health‑care IT, may spur interest in other health‑tech vendors.

Regional

U.S. health‑care technology sector could see modest uplift.

Global

Limited to markets where Oracle Health operates; no broad global effect.

Counterpoint

What could challenge this read

The partnership may be overhyped; adoption could be slow and not materially affect Oracle's earnings.

Key entities

  • Company
    Oracle Corporation

    U.S.-listed software and cloud services provider (ticker ORCL).

  • Company
    Surescripts

    Private e‑prescription network serving the U.S. health‑care market.

Read at source← All news

Related articles

SEP 25
$ORCLMed

Oracle’s AI Project Faces Delivery Test as Market Reassesses “Stargate” Prospects

Oracle (ORCL) faces delays in its AI data center project, Project Jupiter, due to permitting issues for a natural gas pipeline. The company has issued a force majeure notice to delay payments, but insists the project is on schedule. The project, financed by 20 banks, aims to serve Oracle's cloud infrastructure growth, which saw 121% revenue growth. However, Oracle's capital expenditure exceeded operating cash flow, raising concerns about its financial health and project delivery timelines.

nai500.com3 min
SEP 25
$METAMed

U.S. stock futures drift lower as soaring yields, oil prices weigh

U.S. stock futures fell slightly on Thursday evening due to rising Treasury yields and oil prices. S&P 500, Nasdaq 100, and Dow Jones futures declined. Meta gained 4.5% after AI product announcements, while Oracle dropped 5% after a force majeure notice on a data center project. Trump and Xi concluded talks with few details released. The 10-year Treasury yield hit a 19-year high at 5.2%.

investing.com3 min
SEP 25
$ORCLHighAI 8/10

Oracle Shares Fall as New Mexico AI Data Center Faces Power Delays

Oracle Corp. shares fell 4% after reports it issued a force majeure notice for its $165B AI data center in New Mexico, citing power supply delays. The project, powered by Bloom Energy, faces regulatory hurdles and a delayed natural gas pipeline. Analysts note Oracle's tighter cash position may amplify infrastructure risks. Blue Owl Capital and Bloom Energy shares also declined.

econotimes.com2 min
SEP 25
$ORCLMed

Oracle’s Force Majeure Notice Raises Financing Concerns as OpenAI Data Center Faces Yearlong Delay

Oracle issued a force majeure notice for 'Project Jupiter,' a data center for OpenAI, delaying completion by a year. Blue Owl, the project's developer, assured financial commitments remain unchanged. The delay has raised concerns among investors and lenders, affecting financing discussions for other data centers. Rising U.S. interest rates and local opposition to projects are also increasing risks.

mezha.net3 min